Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Clinical Immunology and Immunopathology|January 1, 1993
Monoclonal IgM, IgG, and IgA human rheumatoid factors produced by synovial tissue-derived, EBV-transformed B cell linesS Kaplan, K Hyman, R Brooks, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996
Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patientsR Hingorani, J Monteiro, R Furie, et al.Blood|May 15, 1992
A soluble form of Fc gamma RIII is present in human serum and other body fluids and is elevated at sites of inflammationH B Fleit, C D Kobasiuk, C Daly, et al.The British Journal of Dermatology|January 17, 2018
Computerized planimetry to assess clinical responsiveness in a phase II randomized trial of topical R333 for discoid lupus erythematosusJ K Presto, L G Okon, R Feng, et al.Autoimmunity|January 1, 1995
IgH and L chain variable region gene sequence analyses of twelve synovial tissue-derived B cell lines producing IgA, IgG, and IgM rheumatoid factors structure/function comparisons of antigenic specificity, V gene sequence, and Ig isotypeR I Jain, F Fais, S Kaplan, et al.Lupus|September 30, 2003
Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placeboV Strand, C Aranow, M H Cardiel, et al.Arthritis and Rheumatism|November 19, 1997
Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosisL R Sammaritano, S Ng, R Sobel, et al.Arthritis and Rheumatism|June 3, 2008
Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapyE Keystone, G R Burmester, R Furie, et al.Lupus|December 6, 2012
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosusD J Wallace, S Navarra, M A Petri, et al.Arthritis and Rheumatism|October 18, 2002
High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitisR Kokkola, E Sundberg, A-K Ulfgren, et al.Pageof 3